Jeffrey Johnson, DPM
Podiatrist · Rumford, MENPI 1295899672
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 81.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $1,553 and has fallen 89.8% since, to $159 in 2025.
Across 35 payments — averaging $55.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$2K
- 4web, Inc.$147
- Paratek Pharmaceuticals, Inc.$144
- Hydrofera LLC$29
- Mimedx Group, Inc.$22
- Advanced Oxygen Therapy Inc.$15
What the payments were for
- Speaking & faculty fees$1256%
- Travel & lodging$1,00851%
- Food & beverage$82542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 28 | $1,601 |
| 4web, Inc. | 1 | $147 |
| Paratek Pharmaceuticals, Inc. | 3 | $144 |
| Hydrofera LLC | 1 | $29 |
| Mimedx Group, Inc. | 1 | $22 |
| Advanced Oxygen Therapy Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Puraply, NuShield, Affinity$945
- OSTEOTOMY TRUSS SYSTEM$147
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
- NUZYRA$114
How this compares
$1,958 in reported general payments places this provider in the 65th percentile of 20 podiatrist providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 19 | $274 |
| Cephalexin | 22 | $263 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Rumford
- Christopher TothBiddeford$10K
- Lance HopkinSkowhegan$7K
- Puneet ChahalBrunswick$7K
- Peter OcampoScarborough$6K
- Brian LoringAugusta$3K
- Robert TaylorPortland$3K
- Christopher SaccoLewiston$798
- Robert AndersonBrewer$425
- Shannon MeredithPortland$403
- Andrew LamPatten$369
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.